Loading...
OTC Markets
Totals
Securities
12,348
Dollar Vol
$2.5B
Share Vol
3.4B
Trades
295,731

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

DECN
Decision Diagnostics Corp.

Common Stock

Decision Diagnostics Corp.

2660 Townsgate Road

Suite 300

Westlake Village, CA 91361

Last Verified 06/2022
Business Description
Decision Diagnostics Corp. is a non-prescription diagnostics and home testing products distributor. We market our GenUltimate, PetSure (test strips for dogs and cats) and GenChoice (in FDA 510(k) review), our panacea GenUltimate TBG glucose test strips and meter (internationally), our GenUltimate Precis test strips and meter (for international private label sale), our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses, and finally our GenViro! saliva diagnostic for the testing for the Covid-19 virus (internationally). We are also FDA approved as an establishment manufacturer and have complete R&D and manufacturing facilities in South Korea. We made ...
More
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Unaudited
CIK
0001144225
Fiscal Year End
12/31
Company Officers & Contacts
Keith M Berman
CEO

CEO, CFO, Secretary and Director Specializing in in-vitro diagnostics and healthcare software including intranet and Internet systems for the past 31 years and a founder of Decision Diagnostics Corp., Keith Berman brings more than 39 years experience in the healthcare field, having worked with such companies as Technicon Corporation and Boehringer-Mannheim Corporation. He is the founder of Medicius Inc., and served as that company's president at the time of its acquisition by what is today, Decision Diagnostics Corp. Mr. Berman also was the founder of Cymedix, the operating division of the formerly Amex traded Ramp Corp. (formerly Medix Resources) (AMEX: RCO), formerly a public company. Mr. Berman received his B.A. and M.B.A. from Indiana University.

Board of Directors

Not available

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Securities Counsel
Thomas Cook

10470 W. Cheyenne Ave.

Suite 115, PMB 303

Las Vegas, NV 89129

Profile Data
SIC - Industry Classification
5122 - Drugs, proprietaries, and sundries
Incorporation Information
NV, US, 2001
Employees
4 as of 12/09/2021
Shell
No
Products and Services

Decision Diagnostics Corp. is a non-prescription diagnostics and home testing products manufacturer and distributor. We market our GenUltimate, PetSure (test strips for dogs and cats) and our panacea GenUltimate TBG glucose test strips and meter (internationally), our GenUltimate Precis test strips and meter (for international private label sale), and our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses. We most recently brought to market our GenViro! diagnostic for the professional point of care testing for the Covid-19 virus. We are also FDA approved as an establishment manufacturer and have complete R&D and manufacturing facilities in South Korea. We made the the first alternative glucose testing strips sold to the market in this decade and the first alternative test strip products sold into the market since early 2008.

Company Facilities

We rent 2300 square feet in a multi-unit condo office complex in Westlake Village, CA. We have been at this facility since 2002. We secure space at a Miami, FL public warehouse where we center our importing and exporting of product. And we have space in South Korea for FDA mandated QA and QC activities for our products that is supervised by The Bio Co., our contract manufacturer and product development partner, who like us is registered with the FDA. The Bio also holds registration under several ISO standards.

Company Notes
12(k) Suspension for the period commencing at 9:30 a.m. EDT on April 24, 2020 and terminating at 11:59 p.m. EDT on May 7, 2020.
Formerly=instaCare Corp. until 12-2011
Formerly=CareDecision Corp. until 4-05
Note=3-31-04 company is in the development stage
Formerly=ATR Search Corp. until 8-02
Caveat Emptor Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Buyer Beware: OTC Markets Group has determined that there is a public interest concern associated with the company.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.